• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于带有负项过滤的微阵列表达谱发现疾病、基因和药物之间的隐藏联系。

Discovering hidden connections among diseases, genes and drugs based on microarray expression profiles with negative-term filtering.

作者信息

Wu Jain-Shing, Kao E-Fong, Lee Chung-Nan

机构信息

Department of Computer Science and Engineering, National Sun Yat-Sen University, Kaohsiung, Taiwan.

Department of Medical Imaging and Radiological Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan.

出版信息

PLoS One. 2014 Jun 10;9(6):e98826. doi: 10.1371/journal.pone.0098826. eCollection 2014.

DOI:10.1371/journal.pone.0098826
PMID:24915461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4051596/
Abstract

Microarrays based on gene expression profiles (GEPs) can be tailored specifically for a variety of topics to provide a precise and efficient means with which to discover hidden information. This study proposes a novel means of employing existing GEPs to reveal hidden relationships among diseases, genes, and drugs within a rich biomedical database, PubMed. Unlike the co-occurrence method, which considers only the appearance of keywords, the proposed method also takes into account negative relationships and non-relationships among keywords, the importance of which has been demonstrated in previous studies. Three scenarios were conducted to verify the efficacy of the proposed method. In Scenario 1, disease and drug GEPs (disease: lymphoma cancer, lymph node cancer, and drug: cyclophosphamide) were used to obtain lists of disease- and drug-related genes. Fifteen hidden connections were identified between the diseases and the drug. In Scenario 2, we adopted different diseases and drug GEPs (disease: AML-ALL dataset and drug: Gefitinib) to obtain lists of important diseases and drug-related genes. In this case, ten hidden connections were identified. In Scenario 3, we obtained a list of disease-related genes from the disease-related GEP (liver cancer) and the drug (Capecitabine) on the PharmGKB website, resulting in twenty-two hidden connections. Experimental results demonstrate the efficacy of the proposed method in uncovering hidden connections among diseases, genes, and drugs. Following implementation of the weight function in the proposed method, a large number of the documents obtained in each of the scenarios were judged to be related: 834 of 4028 documents, 789 of 1216 documents, and 1928 of 3791 documents in Scenarios 1, 2, and 3, respectively. The negative-term filtering scheme also uncovered a large number of negative relationships as well as non-relationships among these connections: 97 of 834, 38 of 789, and 202 of 1928 in Scenarios 1, 2, and 3, respectively.

摘要

基于基因表达谱(GEP)的微阵列可以针对各种主题进行专门定制,以提供一种精确且高效的手段来发现隐藏信息。本研究提出了一种利用现有GEP在丰富的生物医学数据库PubMed中揭示疾病、基因和药物之间隐藏关系的新方法。与仅考虑关键词出现情况的共现方法不同,该方法还考虑了关键词之间的负相关关系和非相关关系,先前的研究已证明了其重要性。进行了三种场景验证该方法的有效性。在场景1中,使用疾病和药物GEP(疾病:淋巴瘤、淋巴结癌,药物:环磷酰胺)来获取疾病和药物相关基因列表。在疾病和药物之间识别出15个隐藏联系。在场景2中,采用不同的疾病和药物GEP(疾病:急性髓细胞白血病-急性淋巴细胞白血病数据集,药物:吉非替尼)来获取重要疾病和药物相关基因列表。在这种情况下,识别出10个隐藏联系。在场景3中,我们从疾病相关GEP(肝癌)和PharmGKB网站上的药物(卡培他滨)中获取疾病相关基因列表,得到22个隐藏联系。实验结果证明了该方法在揭示疾病、基因和药物之间隐藏联系方面的有效性。在所提出的方法中实施权重函数后,在每个场景中获得的大量文档被判定为相关:场景1中4028篇文档中的834篇,场景2中1216篇文档中的789篇,场景3中3791篇文档中的1928篇。否定词过滤方案还揭示了这些联系之间的大量负相关关系以及非相关关系:场景1中834篇中的97篇,场景2中789篇中的38篇,场景3中1928篇中的202篇。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/cab0931d94f2/pone.0098826.g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/304266ddd24b/pone.0098826.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/346cf3f58f2b/pone.0098826.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/4a684b79f36d/pone.0098826.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/d57443a18b78/pone.0098826.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/0e3bf0cf0ae1/pone.0098826.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/3a8c21cc5f04/pone.0098826.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/4b51d6491ae0/pone.0098826.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/f83807f6d2e0/pone.0098826.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/7209938bf7e8/pone.0098826.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/0176f08cae5d/pone.0098826.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/53bd7b259b83/pone.0098826.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/f956f0d233d1/pone.0098826.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/4794104f53ce/pone.0098826.g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/cab0931d94f2/pone.0098826.g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/304266ddd24b/pone.0098826.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/346cf3f58f2b/pone.0098826.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/4a684b79f36d/pone.0098826.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/d57443a18b78/pone.0098826.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/0e3bf0cf0ae1/pone.0098826.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/3a8c21cc5f04/pone.0098826.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/4b51d6491ae0/pone.0098826.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/f83807f6d2e0/pone.0098826.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/7209938bf7e8/pone.0098826.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/0176f08cae5d/pone.0098826.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/53bd7b259b83/pone.0098826.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/f956f0d233d1/pone.0098826.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/4794104f53ce/pone.0098826.g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35c1/4051596/cab0931d94f2/pone.0098826.g014.jpg

相似文献

1
Discovering hidden connections among diseases, genes and drugs based on microarray expression profiles with negative-term filtering.基于带有负项过滤的微阵列表达谱发现疾病、基因和药物之间的隐藏联系。
PLoS One. 2014 Jun 10;9(6):e98826. doi: 10.1371/journal.pone.0098826. eCollection 2014.
2
Literature mining for the discovery of hidden connections between drugs, genes and diseases.文献挖掘发现药物、基因和疾病之间隐藏的关联。
PLoS Comput Biol. 2010 Sep 23;6(9):e1000943. doi: 10.1371/journal.pcbi.1000943.
3
Discovering disease-specific biomarker genes for cancer diagnosis and prognosis.发现用于癌症诊断和预后的疾病特异性生物标志物基因。
Technol Cancer Res Treat. 2010 Jun;9(3):219-30. doi: 10.1177/153303461000900301.
4
Human disease-drug network based on genomic expression profiles.基于基因组表达谱的人类疾病-药物网络。
PLoS One. 2009 Aug 6;4(8):e6536. doi: 10.1371/journal.pone.0006536.
5
Prediction of gene-based drug indications using compendia of public gene expression data and PubMed abstracts.利用公共基因表达数据和PubMed摘要汇编预测基于基因的药物适应症。
J Bioinform Comput Biol. 2014 Jun;12(3):1450007. doi: 10.1142/S0219720014500073. Epub 2014 Mar 19.
6
Drug target prioritization by perturbed gene expression and network information.基于基因表达扰动和网络信息的药物靶点优先级排序
Sci Rep. 2015 Nov 30;5:17417. doi: 10.1038/srep17417.
7
Quadratic regression analysis for gene discovery and pattern recognition for non-cyclic short time-course microarray experiments.用于非循环短时间进程微阵列实验的基因发现和模式识别的二次回归分析。
BMC Bioinformatics. 2005 Apr 25;6:106. doi: 10.1186/1471-2105-6-106.
8
PISTON: Predicting drug indications and side effects using topic modeling and natural language processing.PISTON:使用主题建模和自然语言处理预测药物适应证和副作用。
J Biomed Inform. 2018 Nov;87:96-107. doi: 10.1016/j.jbi.2018.09.015. Epub 2018 Sep 27.
9
Mining co-regulated gene profiles for the detection of functional associations in gene expression data.挖掘共调控基因谱以检测基因表达数据中的功能关联。
Bioinformatics. 2007 Aug 1;23(15):1927-35. doi: 10.1093/bioinformatics/btm276. Epub 2007 May 30.
10
High-order dynamic Bayesian Network learning with hidden common causes for causal gene regulatory network.用于因果基因调控网络的具有隐藏共同原因的高阶动态贝叶斯网络学习
BMC Bioinformatics. 2015 Nov 25;16:395. doi: 10.1186/s12859-015-0823-6.

本文引用的文献

1
Genetic variations in CD14 promoter and acute lymphoblastic leukemia susceptibility in a Chinese population.CD14 启动子基因多态性与中国人群急性淋巴细胞白血病易感性的关系。
DNA Cell Biol. 2011 Oct;30(10):777-82. doi: 10.1089/dna.2011.1223. Epub 2011 Apr 10.
2
Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine.大黄素通过调节 Rad51、ERCC1 和胸苷磷酸化酶与卡培他滨联合使用产生协同细胞毒作用。
Biochem Pharmacol. 2011 Mar 1;81(5):680-90. doi: 10.1016/j.bcp.2010.12.008. Epub 2010 Dec 17.
3
Literature mining for the discovery of hidden connections between drugs, genes and diseases.
文献挖掘发现药物、基因和疾病之间隐藏的关联。
PLoS Comput Biol. 2010 Sep 23;6(9):e1000943. doi: 10.1371/journal.pcbi.1000943.
4
Programmed cell death 4 enhances chemosensitivity of ovarian cancer cells by activating death receptor pathway in vitro and in vivo.程序性细胞死亡蛋白 4 通过激活体内外死亡受体通路增强卵巢癌细胞的化疗敏感性。
Cancer Sci. 2010 Oct;101(10):2163-70. doi: 10.1111/j.1349-7006.2010.01664.x. Epub 2010 Aug 24.
5
Luteolin and gefitinib regulation of EGF signaling pathway and cell cycle pathway genes in PC-3 human prostate cancer cells.木犀草素和吉非替尼对人前列腺癌细胞 PC-3 中表皮生长因子信号通路和细胞周期通路基因的调控。
J Steroid Biochem Mol Biol. 2010 Oct;122(4):219-31. doi: 10.1016/j.jsbmb.2010.06.006. Epub 2010 Jun 15.
6
Gefitinib enhances arsenic trioxide (AS2O3)-induced differentiation of acute promyelocytic leukemia cell line.吉非替尼增强三氧化二砷(As2O3)诱导的急性早幼粒细胞白血病细胞系的分化。
Leuk Res. 2010 Nov;34(11):1501-5. doi: 10.1016/j.leukres.2010.02.016. Epub 2010 Mar 11.
7
Building disease-specific drug-protein connectivity maps from molecular interaction networks and PubMed abstracts.从分子相互作用网络和PubMed摘要构建疾病特异性药物-蛋白质连接图谱。
PLoS Comput Biol. 2009 Jul;5(7):e1000450. doi: 10.1371/journal.pcbi.1000450. Epub 2009 Jul 31.
8
Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancer.针对乳腺癌中凋亡蛋白抑制剂与表皮生长因子受体拮抗剂的联合治疗。
Breast Cancer Res. 2009;11(3):R41. doi: 10.1186/bcr2328. Epub 2009 Jun 29.
9
An epidermal growth factor inhibitor, Gefitinib, induces apoptosis through a p53-dependent upregulation of pro-apoptotic molecules and downregulation of anti-apoptotic molecules in human lung adenocarcinoma A549 cells.表皮生长因子抑制剂吉非替尼通过p53依赖性上调促凋亡分子和下调抗凋亡分子,诱导人肺腺癌A549细胞凋亡。
Eur J Pharmacol. 2008 Dec 14;600(1-3):37-44. doi: 10.1016/j.ejphar.2008.10.024. Epub 2008 Oct 21.
10
CoPub: a literature-based keyword enrichment tool for microarray data analysis.CoPub:一种基于文献的用于微阵列数据分析的关键词富集工具。
Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W406-10. doi: 10.1093/nar/gkn215. Epub 2008 Apr 28.